Drahomir Aujesky Selected Research

Therapeutics

2/2024	Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
1/2023	Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study.
1/2023	The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism-an ancillary study within two randomized placebo controlled trials.
1/2023	Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria.
1/2023	Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population.
7/2022	Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study.
3/2022	Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial.
1/2022	Validation of modified GLIM criteria to predict adverse clinical outcome and response to nutritional treatment: A secondary analysis of a randomized clinical trial.
11/2021	Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
11/2021	Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Drahomir Aujesky Research Topics

Disease

38	Pulmonary Embolism 04/2024 - 09/2002
33	Venous Thromboembolism 12/2023 - 03/2004
25	Hemorrhage 12/2023 - 06/2005
16	Neoplasms (Cancer) 01/2023 - 03/2005
15	Hypothyroidism 01/2023 - 07/2006
10	Malnutrition (Nutritional Deficiencies) 01/2023 - 01/2019
7	Frailty 01/2023 - 01/2019
6	Hypertension (High Blood Pressure) 12/2023 - 07/2014
5	Heart Failure 01/2023 - 08/2012
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 03/2004
4	Stroke (Strokes) 02/2024 - 08/2012
4	Infections 12/2023 - 01/2015
4	Coronary Disease (Coronary Heart Disease) 12/2023 - 09/2014
4	Chronic Disease (Chronic Diseases) 01/2023 - 01/2019
4	Anemia 01/2018 - 01/2015
4	Hyperthyroidism 01/2017 - 08/2012
4	Diabetes Mellitus 01/2017 - 07/2014
3	Transient Ischemic Attack 02/2024 - 08/2012
3	Atrial Fibrillation 12/2023 - 01/2021
3	Critical Illness (Critically Ill) 03/2022 - 01/2019
3	Inflammation (Inflammations) 01/2020 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2019
2	Thrombophilia 01/2023 - 07/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2016
2	Thyroid Diseases (Thyroid Disease) 01/2023 - 12/2022
2	Chronic Renal Insufficiency 01/2022 - 11/2016
2	Subacute Sclerosing Panencephalitis (SSPE) 11/2020 - 12/2019
2	Myocardial Infarction 01/2019 - 01/2015
2	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2015
2	Pneumonia (Pneumonitis) 09/2005 - 04/2005
1	Hemorrhagic Stroke 02/2024
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023
1	Thromboembolism 06/2023
1	Dementia (Dementias) 01/2023
1	Hyperhomocysteinemia 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Sarcopenia 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Portal Hypertension 01/2022

Drug/Important Bio-Agent (IBA)

18	AnticoagulantsIBA 12/2023 - 01/2006
14	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023 - 07/2006
11	fibrin fragment D (D-dimer)IBA 12/2018 - 12/2003
9	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2023 - 03/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
7	Thyroid HormonesIBA 01/2023 - 01/2017
6	C-Reactive ProteinIBA 01/2020 - 12/2003
5	TroponinIBA 12/2019 - 10/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 10/2019
4	Vitamin K FDA Link 11/2021 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
4	Troponin T (Troponin T1)IBA 01/2020 - 01/2016
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2019 - 03/2005
3	LipidsIBA 02/2024 - 01/2023
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2022 - 01/2017
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2019 - 03/2014
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 03/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 12/2020
2	AntibodiesIBA 12/2022 - 09/2014
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 01/2018
2	RivaroxabanIBA 11/2020 - 01/2016
2	EnzymesIBA 10/2017 - 03/2004
2	ImmunosorbentsIBA 10/2017 - 03/2004
2	Warfarin (Coumadin)FDA LinkGeneric 06/2005 - 03/2005
1	Proprotein Convertase 9IBA 02/2024
1	Fibric Acids (Fibrates)IBA 02/2024
1	Triglycerides (Triacylglycerol)IBA 02/2024
1	Ezetimibe (Zetia)FDA Link 02/2024
1	oxidized low density lipoproteinIBA 02/2024
1	LDL CholesterolIBA 02/2024
1	Thrombin FDA Link 09/2023
1	ThrombomodulinIBA 09/2023
1	vinyltriethoxysilane (VTES)IBA 06/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	HomocysteineIBA 01/2023
1	cupric sulfide (CuS)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Serum AlbuminIBA 03/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	DiureticsIBA 01/2022
1	CatecholaminesIBA 12/2021
1	CreatinineIBA 10/2021
1	Hypnotics and Sedatives (Sedatives)IBA 09/2021
1	BenzodiazepinesIBA 09/2021

Therapy/Procedure

32	Therapeutics 02/2024 - 03/2005
11	Length of Stay 04/2024 - 01/2008
11	Nutritional Support (Artificial Feeding) 01/2023 - 01/2019
7	Polypharmacy 01/2023 - 01/2015
3	Ambulatory Care (Outpatient Care) 12/2019 - 11/2008
2	Thrombolytic Therapy 12/2010 - 11/2008
2	Patient Readmission 11/2010 - 02/2009
1	Home Nursing (Nursing, Home) 01/2022
1	Cardiopulmonary Resuscitation (CPR) 12/2021
1	Urinary Catheters 09/2021